Natural History of Cirrhosis: Changing Trends in Etiology Over the Years

Ramazan Idilman1, Merve Aydogan2, Mehmet Berk Oruncu2

  • 1Department of Gastroenterology, Ankara University School of Medicine, Ankara, Turkey, idilman@medicine.ankara.edu.tr.

Insights

Hepatitis B and C are leading causes of cirrhosis and liver cancer, but nonalcoholic fatty liver disease is an increasing concern. This study tracked cirrhosis patients to understand disease progression and causes.

Area of Science:

  • Hepatology
  • Gastroenterology
  • Epidemiology

Background:

  • Cirrhosis is a significant health concern with evolving etiological trends.
  • Understanding the natural history of cirrhosis is crucial for patient management and public health strategies.

Purpose of the Study:

  • To investigate the natural history of cirrhosis.
  • To determine the etiological trends in cirrhosis development.
  • To analyze the incidence and risk factors for hepatocellular carcinoma (HCC) in cirrhotic patients.

Main Methods:

  • A retrospective analysis of 1,341 patients diagnosed with cirrhosis between 2001 and 2018.
  • Follow-up data for 898 patients with cirrhosis for at least 6 months.
  • Logistic regression analysis to identify factors associated with HCC development.

Main Results:

  • Chronic viral hepatitis (Hepatitis B virus [HBV] and Hepatitis C virus [HCV]) was the most frequent cause (58%).
  • Nonalcoholic fatty liver disease (NAFLD)-related cirrhosis is a growing concern, potentially increasing from 1.8% to 8.0%.
  • Hepatocellular carcinoma (HCC) developed in 80 patients during follow-up, associated with older age, male gender, viral etiology, and high AST levels.

Conclusions:

  • HBV and HCV remain primary causes of cirrhosis and HCC.
  • NAFLD-related cirrhosis represents an emerging and significant public health challenge.
  • The findings highlight the need for updated strategies to address the changing landscape of cirrhosis etiology.
Abstract

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.7K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
95
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
815
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
118
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
526
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.0K